HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Connie Jackaman Selected Research
Connie Jackaman Research Topics
Disease
17
Neoplasms (Cancer)
01/2022 - 11/2003
10
Mesothelioma
01/2022 - 11/2003
2
Infections
01/2019 - 01/2014
2
Cachexia
01/2019 - 01/2018
2
Inflammation (Inflammations)
11/2008 - 07/2005
1
Acquired Immunodeficiency Syndrome (AIDS)
01/2018
1
Body Weight (Weight, Body)
01/2018
1
Necrosis
01/2018
1
Peripheral Nervous System Diseases (PNS Diseases)
01/2018
1
Lewis Lung Carcinoma
08/2006
1
Malignant Mesothelioma
07/2005
Drug/Important Bio-Agent (IBA)
6
Interleukin-2 (IL2)
IBA
06/2012 - 11/2003
5
Neoplasm Antigens (Tumor Antigens)
IBA
01/2019 - 08/2006
5
Antigens
IBA
01/2019 - 07/2005
4
Cytokines
IBA
01/2019 - 07/2005
3
Epitopes
IBA
01/2019 - 08/2006
3
Ovalbumin
IBA
01/2019 - 08/2006
2
Interleukin-12 (IL 12)
IBA
01/2018 - 07/2005
2
Lipids
IBA
01/2015 - 01/2014
2
Cisplatin (Platino)
FDA Link
Generic
01/2013 - 12/2012
1
Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)
IBA
01/2022
1
Macrophage Colony-Stimulating Factor
IBA
01/2022
1
Perforin
IBA
01/2018
1
Stavudine (Zerit)
FDA Link
Generic
01/2018
1
Conditioned Culture Media
IBA
06/2016
1
Gemcitabine
FDA Link
06/2016
1
Triglycerides (Triacylglycerol)
IBA
01/2015
1
Lipoproteins (Lipoprotein)
IBA
01/2015
1
LDL Lipoproteins (beta Lipoproteins)
IBA
01/2015
1
Copper
IBA
01/2013
1
Penicillamine (Cuprimine)
FDA Link
01/2013
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2013
1
Chelating Agents
IBA
01/2013
1
Trientine (Trien)
FDA Link
01/2013
1
tetrathiomolybdate (ammonium tetrathiomolybdate)
IBA
01/2013
1
Histocompatibility Antigens Class I
IBA
12/2012
1
Therapeutic Uses
IBA
06/2012
1
Autoantigens
IBA
02/2011
1
Immunoglobulins (Immunoglobulin)
IBA
02/2011
1
Vaccines
IBA
11/2008
1
poly-N-acetyl glucosamine
IBA
07/2005
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
07/2005
1
Polymers
IBA
07/2005
Therapy/Procedure
8
Immunotherapy
01/2018 - 11/2003
6
Therapeutics
01/2022 - 11/2003
5
Drug Therapy (Chemotherapy)
01/2019 - 11/2008
1
Withholding Treatment
06/2016
1
Rejuvenation
06/2014